Atlas Trials

Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries

Clinical trial NCT07539844 · RECRUITING

Trial details

NCT number
NCT07539844
Sponsor
AbbVie
Status
RECRUITING
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2026-07-02
Primary completion
2027-03-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.